<DOC>
	<DOCNO>NCT02828592</DOCNO>
	<brief_summary>Severe aplastic anemia rare serious form bone marrow failure relate immune-mediated mechanism result severe pancytopenia high risk infection bleed . Patients match sibling donor transplantation 80-90 % chance survival ; however , response rate immunosuppression patient lack suitable HLA-matched related sibling 60 % . With immunosuppression , 1/3 patient cure , 1/3 dependent long term immunosuppression , 1/3 relapse develop clonal disorder . Recent study show use haploidentical donor transplantation good response rate significantly low rate acute chronic GVHD .</brief_summary>
	<brief_title>Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide Patients With Severe Aplastic Anemia</brief_title>
	<detailed_description>Mismatched haploidentical donor identify patient severe aplastic anemia . These patient undergo preparative regimen Fludarabine/Cyclophosphamide/TBI follow haploidentical bone marrow transplantation . Post-transplant Cyclophosphamide administer Days 3 &amp; 4 . Immunosuppression Tacrolimus MMF begin Day +5 ; MMF discontinue Day +35 Tacrolimus continue Day +180 . Investigators hypothesize haploidentical transplantation above-mentioned preparative regimen &lt; 30 % graft failure rate . The one-sided exact Binomial test 5 % significance level use test hypothesis . The size 20 patient provide power 92.5 % confirm 30-day graft failure rate &lt; 30 % .</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Anemia , Aplastic</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Fludarabine phosphate</mesh_term>
	<mesh_term>Fludarabine</mesh_term>
	<criteria>Availability 3/6 5/6 match ( HLAA , B , DR ) relate donor must negative HLA crossmatch host vs. graft direction Age &lt; = 65 year previously treat &lt; = 75 year previously treat patient KPS &gt; = 70 % Aplastic Anemia meet follow criterion : Peripheral Blood ( must fulfill 2 3 ) : &lt; 500 PMN/mm3 &lt; 20,000 platelet absolute reticulocyte count &lt; 40,000/microL Bone Marrow ( must either ) : markedly hypocellular ( &lt; 25 % normal cellularity ) moderately hypocellular 70 % nonmyeloid precursor patient meet peripheral blood criterion poor cardiac function ( LVEF &lt; 40 % ) poor pulmonary function ( FEV1 &amp; FVC &lt; 50 % predict ) poor liver function ( bili &gt; = 2mg/dL ) poor renal function ( creatinine &gt; = 2.0mg/dL creatinine clearance &lt; 40mL/min ) prior allogeneic transplant</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>SAA</keyword>
</DOC>